Mitsubishi Ufj Asset Management (Uk) Ltd. Supernus Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Asset Management (Uk) Ltd.

$192 Million
Q3 2024

A detailed history of Mitsubishi Ufj Asset Management (Uk) Ltd. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Asset Management (Uk) Ltd. holds 24,000 shares of SUPN stock, worth $889,199. This represents 0.39% of its overall portfolio holdings.

Number of Shares

24,000

Previous 24,000 -0.0%

Holding current value

$889,199

Previous $642,000 16.51%

% of portfolio

0.39%

Previous 0.33%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$27.57 - $32.91 $275,700 - $329,099	-10,000 Reduced 29.41%	24,000 $661,000
Q2 2023 Jul 27, 2023	BUY	$29.91 - $38.73 $59,820 - $77,460	2,000 Added 6.25%	34,000 $1.02 Million
Q1 2023 May 02, 2023	SELL	$34.93 - $42.03 $384,230 - $462,330	-11,000 Reduced 25.58%	32,000 $1.16 Million
Q4 2021 Feb 07, 2022	BUY	$26.37 - $34.22 $210,960 - $273,760	8,000 Added 22.86%	43,000 $1.25 Million
Q3 2021 Oct 19, 2021	BUY	$23.54 - $31.39 $823,900 - $1.1 Million	35,000 New	35,000 $933,000
Q3 2019 Nov 04, 2019	SELL	$25.47 - $33.37 $573,075 - $750,825	-22,500 Closed	0 $0
Q2 2019 Jul 18, 2019	SELL	$29.96 - $38.87 $149,800 - $194,350	-5,000 Reduced 18.18%	22,500 $0
Q4 2018 Jan 22, 2019	BUY	$30.84 - $49.51 $308,400 - $495,100	10,000 Added 57.14%	27,500 $913,000
Q3 2018 Oct 17, 2018	BUY	$42.7 - $56.55 $170,800 - $226,200	4,000 Added 29.63%	17,500 $0
Q2 2018 Jul 18, 2018	BUY	$44.1 - $59.85 $595,350 - $807,975	13,500 New	13,500 $0
Q2 2018 Jul 16, 2018	SELL	$44.1 - $59.85 $595,350 - $807,975	-13,500 Closed	0 $0
Q1 2018 Apr 17, 2018	SELL	$37.15 - $46.9 $743,000 - $938,000	-20,000 Reduced 59.7%	13,500 $0
Q4 2017 Jan 19, 2018	BUY	$36.4 - $42.6 $1.22 Million - $1.43 Million	33,500	33,500 $0

Others Institutions Holding SUPN

# of Institutions

281

Shares Held

60.6M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.98B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Asset Management (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Asset Management (Uk) Ltd. with notifications on news.

Account

Mitsubishi Ufj Asset Management (Uk) Ltd. Supernus Pharmaceuticals, Inc. Transaction History